Source: Journal of Clinical Oncology. Unidade: FM
Subjects: LINFOMA (TERAPIA), MEDICAÇÃO INTRAVENOSA, ANTINEOPLÁSICOS (ADMINISTRAÇÃO E DOSAGEM)
ABNT
SALAR, Antonio et al. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology, v. 32, n. 17, p. 1782-1791, 2014Tradução . . Disponível em: https://doi.org/10.1200/JCO.2013.52.2631. Acesso em: 23 maio 2024.APA
Salar, A., Avivi, I., Bittner, B., Bouabdallah, R., Brewster, M., Catalani, O., et al. (2014). Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology, 32( 17), 1782-1791. doi:10.1200/JCO.2013.52.2631NLM
Salar A, Avivi I, Bittner B, Bouabdallah R, Brewster M, Catalani O, Follows G, Haynes A, Hourcade-Potelleret F, Janikova A, Larouche J-F, McIntyre C, Pedersen M, Pereira J, Sayyed P. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study [Internet]. Journal of Clinical Oncology. 2014 ; 32( 17): 1782-1791.[citado 2024 maio 23 ] Available from: https://doi.org/10.1200/JCO.2013.52.2631Vancouver
Salar A, Avivi I, Bittner B, Bouabdallah R, Brewster M, Catalani O, Follows G, Haynes A, Hourcade-Potelleret F, Janikova A, Larouche J-F, McIntyre C, Pedersen M, Pereira J, Sayyed P. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study [Internet]. Journal of Clinical Oncology. 2014 ; 32( 17): 1782-1791.[citado 2024 maio 23 ] Available from: https://doi.org/10.1200/JCO.2013.52.2631